Alacizumab (Anti-VEGFR2 / KDR / CD309)Alacizumab (Anti-VEGFR2 / KDR / CD309)
Move your mouse over image or click to enlarge

Alacizumab (Anti-VEGFR2 / KDR / CD309)

Alacizumab (Anti-VEGFR2 / KDR / CD309) is a humanized monoclonal antibody targeting VEGFR2 / KDR / CD309 . It has anti-tumour effect in tumour growth. MW :144.08 KD.
Cat# Size Price Qty Buy
A3109-1mg*25 1mg*25
£4,152.00
A3109-1mg*5 1mg*5
£1,384.00
A3109-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A3109

Related Documents